OSTEO FLEX, 30 capsule (ARTRITA, OSTEOARTRITA, ARTROZE, REUMATISM, DURERI INCHEIETURI, Te Scapa de Dureri)

• Marca: SMART LIVING*
• Rating: [0] voturi

-OSTEO FLEX, 30 capsule (ARTRITA, OSTEOARTRITA, ARTROZE, REUMATISM, DURERI INCHEIETURI, Te Scapa de Dureri)

-Informatii produs:
-Osteo Flex conţine un ingredient în noutate în Romania, produsul patentat MSM OptiMSM R precum şi glucozamina şi condroitin produse în Statele Unite şi nu în China

-Produsul Osteo-Flex contine trei ingrediente foarte importante in combaterea simptomelor legate de artroze.
-CONDROITIN:
-Condroitina se gaseşte, sub formă naturală în cartilajul de rechin sau bovine
-Sulfatul de condroitină este o combinaţie a condroitinei cu săruri minerale
-Numeroase studii clinice au demonstrat eficienţa sulfatului de condroitină în:
-Artrite
-Osteoatroze
-Imbunatăţirea mobilităţii articulare

-D-Glucozamina HCL:
-Este un aminoacid important, parte integrantă a cartilajului normal.
-Cartilajul se comportă ca un tampon între oasele ce formează o articulaţie.
-Glucozamina poate fi administrată ca un supliment nutritiv pentru pentru asigurarea funcţionării în condiţii optime a cartilajelor articulare
-Studii clinice dublu-orb placebo-controlate au arătat eficacitatea administrării glucozaminei în osteoartroze
-S-a observat imbunătăţirea mobilităţii articulare, scăderea frecvenţei şi intensităţii durerilor, îmbunătăţirea calităţii vieţii.

-OptiMSMR:
-Un nou studiu Universitar demonstrează o " Acţiune Protectivă" a OptiMSM® asupra cartilajelor articulaţiilor
-Studiul sugerează faptul că OptiMSM ® protejează cartilajele articulaţiilor

-Rezultatele cercetarilor au fost prezentate la Conferinţa Asociaţia Internatională de Cercetări în domeniul Osteoartritei (OARSI), December 6, 2007.

- De ce Osteo-Flex ?
• Produsul Osteo-Flex contine ingrediente fabricate in USA (si nu in China ca majoritatea celorlate produse de pe piata).
• Ingredientele prezente in acest produs sint produse dupa norme GMP si sint la cea mai inalt nivel de puritate, find patentate si marca inregistrata.
• In plus fata de glucozamina si condroitin Osteo-Flex contine MSM Optipure®; Un nou studiu Universitar demonstreaza o " Actiune Protectiva" a OptiMSM® asupra cartilajelor articlatiilor. Studiul sugereaza faptul ca OptiMSM ® protejeaza cartilajele articulatiilor.

-Compozitie:
-Potasiu............................................................................................225 mg
-Sulfat de Chondroitin.....................................................................1500 mg
-D-Glucozamina Sulfat 2kl..............................................................1500 mg
-MSM OptiMSM R.............................................................................105 mg

-Instructiuni de folosire:
-Doza zilnica = 3 tablete
-Ca supliment nutritiv = 3 tablete pe zi

-Studii clinice care confirma calitatile acestui produs:
-Glucosamine and Chondroitin Sulfate References
Karel Pavelká, MD, PhD; Jindriska Gatterová, MD; Marta Olejarová, MD; Stanislav Machacek, MD; Giampaolo Giacovelli, PhD; Lucio C. Rovati, MD. Glucosamine Sulfate Use and Delay of Progression of Knee Osteoarthritis A 3-Year, Randomized, Placebo-Controlled, Double-blind Study. Arch Intern Med. 2002;162:2113-2123
Reginster JY, Gillot V, Bruyere O, Henrotin Y. Evidence of nutriceutical effectiveness in the treatment of osteoarthritis. Curr Rheumatol Rep 2000; 2: 472-77.
Constantz RB. Hyaluronan, glucosamine and chondroitin sulfate: roles for therapy in arthritis? In: Kelley WN, Harris ED, Ruddy S, Sledge CB, eds. Textbook of rheumatology. Philadelphia: WB Saunders, 1998.
Deal CL, Moskowitz RW. Nutraceuticals as therapeutic agents in osteoarthritis: the role of glucosamine, chondroitin sulfate, and collagen hydrolysate. Rheum Dis Clin North Am 1999; 25: 379-95.
McAlindon TE, LaValley MP, Gulin JP, Felson DT. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA 2000; 283: 1469-75.
University Study Shows "Protective Action" of OptiMSM®
on Articular Cartilage

The first mechanism of action study suggests that OptiMSM may protect articular cartilage.

Findings Presented at the OsteoArthritis Research Society International (OARSI) Conference, December 6, 2007.

San Diego, CA, December 7, 2007--Researchers from the University of California, San Diego presented new research findings yesterday at the 2007 World Congress on Osteoarthritis in Ft. Lauderdale, providing the first evidence of how methylsulfonylmethane (MSM) may protect articular cartilage and reduce inflammation in osteoarthritis. The form of MSM used in the study, OptiMSM was provided by Bergstrom Nutrition, Vancouver WA.
The study examined the effect of OptiMSM on healthy and osteoarthritic articular cartilage from post mortem human knees. Researchers focused on the expression of specific genes related to cartilage degradation and markers of inflammation, called cytokines. Over-expression of these genes and their related proteins are associated with the progression of osteoarthritis.
The study showed reduced expression of genes for pro-inflammatory cytokines and cartilage degrading enzymes. "It suggests that MSM acts as a barrier, shielding cartilage in early stages of osteoarthritis from further degeneration from inflammatory cytokines and cartilage degrading enzymes," says cartilage biology expert and lead researcher, David Amiel, Ph.D., Connective Tissue Biochemistry, Department of Orthopaedic Surgery, University of California San Diego. The research team also included Yasushi Oshima, M.D., Ph.D. "This initial exploratory study aligns with the clinical evidence previously published by Kim et al. in Osteoarthritis and Cartilage Journal, March 2006, both on OptiMSM," Dr. Amiel added.
The researchers point out that, while the in vitro study is significant in revealing the protective action of OptiMSM, additional investigations are required to specify the optimum dose concentration for use in supplements by humans. The generally recommended dosage is 1,500 to 6,000 mg of MSM per day. More research is being planned for 2008.